Search

Compugen Ltd

Uždarymo kaina

2.54 -1.17

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.5300000000000002

Max

2.61

Pagrindiniai rodikliai

By Trading Economics

Pajamos

663K

-7M

Pardavimai

426K

2.6M

P/E

Sektoriaus vid.

6.816

56.597

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-269.254

Darbuotojai

75

EBITDA

665K

-7M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+95.31% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-09

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

20M

245M

Ankstesnė atidarymo kaina

3.71

Ankstesnė uždarymo kaina

2.54

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-08 23:56; UTC

Compass Minerals International Inc shares are lower in after-market hours, with no specific news identified. Broader market expectations for an interest rate hike persist.

2026-09-08 23:56; UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, despite fluctuations, and remain above their 20-day moving average.

2026-09-08 23:56; UTC

NextDecade Corp shares gained slightly in after-market trading. The stock remains above its 20-day moving average amid broader economic influences.

2026-09-08 23:56; UTC

Arrow Financial Corp shares are lower in after-market hours with no specific news identified. The stock has recovered from an initial decline.

2026-09-08 23:56; UTC

Qualys Inc shares are lower in after-market trading amid broader market weakness. The stock has declined for three consecutive sessions.

2026-09-08 23:56; UTC

Correlated Moves

Illinois Tool Works Inc shares are lower in after-market trading, reflecting broader industrial sector trends and influenced by declines in Lincoln Electric Holdings Inc.

2026-09-08 23:56; UTC

PPL Corp shares are higher in after-market trading, reflecting broader market sentiment following a strong jobs report that raised interest rate hike expectations.

2026-09-08 23:56; UTC

Correlated Moves

Samsara Inc shares are lower in after-market hours, influenced by ServiceTitan Inc's significant drop and broader market concerns over potential interest rate hikes.

2026-09-08 23:56; UTC

News

Korn Ferry's Board declared a quarterly cash dividend of $0.55 per share, payable October 15. Shares traded roughly flat in after-market hours.

2026-09-08 23:56; UTC

Mastercraft Boat Holdings Inc. shares were roughly flat in after-market hours, reflecting minimal price movement amid ongoing performance challenges.

2026-09-08 23:56; UTC

Comcast Corp shares are lower in after-market trading, following a session low. Recent economic data has influenced market expectations for potential interest rate hikes.

2026-09-08 23:56; UTC

Brown & Brown Inc shares are lower in after-market hours, reflecting broader market concerns over a potential interest rate hike following a strong jobs report.

2026-09-08 23:56; UTC

Cytokinetics Inc shares are higher in after-market trading, reflecting broader market sentiment following a strong jobs report and rising interest rate expectations.

2026-09-08 23:56; UTC

Social Media
News

Chevron Corp shares are higher in after-market hours following a report on declining OECD strategic petroleum reserves, which may impact oil prices and benefit the company.

2026-09-08 23:52; UTC

Ovid Therapeutics Inc is higher in after-market trading, reflecting positive momentum since Tuesday's close and positioning above its 20-day moving average.

2026-09-08 23:52; UTC

Cardinal Health Inc shares are lower in after-market hours, with volatility noted despite no specific company news or developments influencing the decline.

2026-09-08 23:51; UTC

CVR Energy Inc shares are higher in after-market trading, recovering from earlier volatility. Rising crude oil prices may be influencing market dynamics.

2026-09-08 23:51; UTC

Harley-Davidson Inc shares are higher in after-market trading, reflecting volatility amid rising crude oil prices and inflation concerns following a strong jobs report.

2026-09-08 23:51; UTC

Huron Consulting Group Inc shares are lower in after-market trading, retracing from an earlier session high and remaining below the 20-day moving average.

2026-09-08 23:51; UTC

Range Resources Corp shares are higher in after-market trading, buoyed by rising crude oil prices nearing $99 per barrel and a strong jobs report.

2026-09-08 23:51; UTC

Gold Resource Corp shares are lower in after-market hours amid rising crude oil prices and inflation concerns ahead of the Federal Reserve meeting.

2026-09-08 23:51; UTC

Brazil's Retail Sales MoM report on September 15, 2026, expected to reveal consumer spending trends and impact economic growth outlook.

2026-09-08 23:51; UTC

South Korea's unemployment rate drops to 2.7% in August, signaling strong job growth and positive investor sentiment amidst global economic uncertainties.

2026-09-08 23:51; UTC

Japan's July Machinery Orders Expected to Reflect Positive Capital Spending Trends Amidst Economic Recovery and Investor Optimism

2026-09-08 23:51; UTC

Japan's Trade Balance Data Release on September 15, 2026: Market Braces for Persistent Deficits Amid Weak Yen and Geopolitical Tensions.

2026-09-08 23:51; UTC

Japan's upcoming exports data release on September 15, 2026, is anticipated to reflect continued reliance on high-tech products amid positive economic indicators and rising real wages, despite global market uncertainties.

2026-09-08 23:51; UTC

Ambarella Inc. showed unusual strength in after-market trading, advancing despite rising crude oil prices and inflation concerns. No specific news was identified for the move.

2026-09-08 23:51; UTC

ETSY Inc. shares are higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

2026-09-08 23:51; UTC

Shares of United Airlines Holdings Inc. are higher in after-market trading, though they remain below the 20-day moving average and near the one-month range low.

2026-09-08 23:51; UTC

Illumina Inc shares are higher in after-market trading, showing notable activity and positioning above the 20-day moving average amid a lack of specific news.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

95.31% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  95.31%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat